Vascular function and glucose variability improve transiently following initiation of continuous subcutaneous insulin infusion in children with type 1 diabetes

Pediatric Diabetes

Volumn 14, Issue 7, 2013, Pages 504-511

  Harrington, Jennifer ^a   Peña, Alexia S ^a   Wilson, Louise ^a   Gent, Roger ^b   Dowling, Kate ^b   Baghurst, Peter ^b   Couper, Jennifer ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Atherosclerosis; Endothelium; Insulin infusion systems; Type 1 diabetes; Vascular

Indexed keywords

C REACTIVE PROTEIN; FRUCTOSAMINE; GLUCOSE; GLYCERYL TRINITRATE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BIOCHEMISTRY; BLOOD FLOW; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL FUNCTION; BODY MASS; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE VARIABILITY; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; TREATMENT REFUSAL; VASODILATATION;

ATHEROSCLEROSIS; ENDOTHELIUM; INSULIN INFUSION SYSTEMS; TYPE 1 DIABETES; VASCULAR;

ADOLESCENT; BLOOD GLUCOSE; CHILD; HUMANS; INFUSIONS, SUBCUTANEOUS; INSULIN; NITROGLYCERIN; REGIONAL BLOOD FLOW; VASODILATION;

EID: 84886641438     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12050     Document Type: Article

References (39)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001: 414: 813-820.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
3. Kilpatrick ES, Rigby AS, Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009: 32: 1901-1903.
4. Sun J, Xu Y, Dai Z, Sun Y. Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin. Mol Cell Endocrinol 2009: 313: 64-69.
5. Ceriello A, Esposito K, Piconi L et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008: 57: 1349-1354.
6. Buscemi S, Re A, Batsis JA et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med 2010: 27: 872-878.
7. Gordin D, Ronnback M, Forsblom C, Makinen V, Saraheimo M, Groop PH. Glucose variability, blood pressure and arterial stiffness in type 1 diabetes. Diabetes Res Clin Pract 2008: 80: e4-e7.
8. Piconi L, Quagliaro L, Assaloni R et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 2006: 22: 198-203.
9. Bragd J, Adamson U, Backlund LB, Lins PE, Moberg E, Oskarsson P. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab 2008: 34: 612-616.
10. Pena AS, Couper JJ, Harrington J et al. Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes. Diabetes Technol Ther 2012: 14: 457-462.
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993: 362: 801-809.
12. Jarvisalo MJ, Lehtimaki T, Raitakari OT. Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation 2004: 109: 2885-2889.
13. Wiltshire EJ, Gent R, Hirte C, Pena A, Thomas DW, Couper JJ. Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 2002: 51: 2282-2286.
14. Kwagyan J, Hussein S, Xu S et al. The relationship between flow-mediated dilatation of the brachial artery and intima-media thickness of the carotid artery to Framingham risk scores in older African Americans. J Clin Hypertens (Greenwich) 2009: 11: 713-719.
15. Polak JF, Pencina MJ, O'Leary DH, D'Agostino RB. Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke 2011: 42: 3017-3021.
16. Neunteuf T, Katzenschlager R, Hassan A et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997: 129: 111-118.
17. Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus. Diabetes Technol Ther 2007: 9: 339-347.
18. Bruttomesso D, Crazzolara D, Maran A et al. In type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008: 25: 326-332.
19. Pickup JC, Kidd J, Burmiston S, Yemane N. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006: 22: 232-237.
20. Alemzadeh R, Loppnow C, Parton E, Kirby M. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther 2003: 5: 167-173.
21. MacKenzie KE, Wiltshire EJ, Gent R, Hirte C, Piotto L, Couper JJ. Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics 2006: 118: 242-253.
22. Harrington J, Pena AS, Gent R, Hirte C, Couper J. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr 2010: 156: 237-241.
23. Cameron FJ, Donath SM, Baghurst PA. Measuring glycaemic variation. Curr Diabetes Rev 2010: 6: 17-26.
24. Baghurst PA. Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther 2011: 13: 296-302.
25. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970: 19: 644-655.
26. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005: 7: 253-263.
27. Service FJ, O'Brien PC, Rizza RA. Measurements of glucose control. Diabetes Care 1987: 10: 225-237.
28. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR. A method for assessing quality of control from glucose profiles. Diabetic Med 2007: 24: 753-758.
29. McCall AL, Cox DJ, Crean J, Gloster M, Kovatchev BP. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther 2006: 8: 644-653.
30. Ceriello A, Novials A, Ortega E et al. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes 2012: 61: 2993-2997.
31. Ceriello A, Kumar S, Piconi L, Esposito K, Giugliano D. Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes. Diabetes Care 2007: 30: 649-654.
32. Azuma K, Kawamori R, Toyofuku Y et al. Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 2006: 26: 2275-2280.
33. Ceriello A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008: 31 (Suppl. 2): S181-S184.
34. Overgaard Larsen I, Svensson J, Olsen B, Lyngsoe L, Thomsen J, Johannesen J. Characterization of metabolic responders on insulin pump treatment amongst children and adolescents in Denmark from 2007-2012. Pediatr Diabetes 2012: 13: 40.
35. Olsen B, Svensson J, Johannesen J, Mortensen H, Fredheim S. Predictors for better metabolic outcome in children treated with CSII. Pediatr Diabetes 2012: 13: 41.
36. O'Connell MA, Donath S, Cameron FJ. Poor adherence to integral daily tasks limits the efficacy of CSII in youth. Pediatr Diabetes 2011: 12: 556-559.
37. Phillip M, Danne T, Shalitin S et al. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes 2012: 13: 215-228.
38. Weinzimer S, Xing D, Tansey M et al. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatr Diabetes 2009: 10: 91-96.
39. Kordonouri O, Hartmann R, Pankowska E et al. Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study. Pediatr Diabetes 2012: 13: 515-518.